A recent study comparing these kits to IHC and FISH in a subset of 37 patients with NSCLC, found that the Archer® FusionPlex® kit accurately classified all samples, and permitted the correct identification of one rare DCTN1 (dynactin subunit 1)-ALK fusion, one novel CLIP1 (CAP-GLY domain-containing linker protein 1)-ALK fusion, and one novel GCC2 (GRIP and coiled-coil domain-containing protein 2)-ALK transcript. Here, DCTN1 is linked to non-small cell lung carcinoma.